Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Schorb

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Blood|April 16, 2026
Mapping risk and therapy in secondary CNS lymphomaElisabeth Schorb
Deutsche Medizinische Wochenschrift (1946)|February 1, 2019
[Current Treatment Standards in PCNSL]Elisabeth Schorb, Gerald Illerhaus, Jürgen Finke
Blood|July 11, 2018
Novel agents for primary central nervous system lymphoma: evidence and perspectivesGerald Illerhaus, Elisabeth Schorb, Benjamin Kasenda
British Journal of Haematology|August 27, 2021
Advances in treatment of elderly primary central nervous system lymphomaNicolas Martinez-Calle, Lisa K Isbell, Kate Cwynarski, et al.
BMC Cancer|March 31, 2019
Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patientsElisabeth Schorb, Juergen Finke, Gabriele Ihorst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 25, 2010
Primary CNS lymphoma--radiation-free salvage therapy by second autologous stem cell transplantationBenjamin Kasenda, Elisabeth Schorb, Kristina Fritsch, et al.
International Journal of Adolescent Medicine and Health|December 23, 2008
Marked smoking-associated increase of cardiovascular risk in childhood type 1 diabetesKarl Otfried Schwab, Jürgen Doerfer, Kristiane Hallermann, et al.
Blood Advances|July 30, 2020
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot studyElisabeth Schorb, Benjamin Kasenda, Gabriele Ihorst, et al.
Cancers|September 10, 2021
Treatment Regimens for Immunocompetent Elderly Patients with Primary Central Nervous System Lymphoma: A Scoping ReviewElisabeth Schorb, Lisa Kristina Isbell, Gerald Illerhaus, et al.
Annals of Hematology|March 30, 2012
The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patientsBenjamin Kasenda, Marcel Rehberg, Petra Thürmann, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Blood|April 16, 2026
Mapping risk and therapy in secondary CNS lymphomaElisabeth Schorb
Deutsche Medizinische Wochenschrift (1946)|February 1, 2019
[Current Treatment Standards in PCNSL]Elisabeth Schorb, Gerald Illerhaus, Jürgen Finke
Blood|July 11, 2018
Novel agents for primary central nervous system lymphoma: evidence and perspectivesGerald Illerhaus, Elisabeth Schorb, Benjamin Kasenda
British Journal of Haematology|August 27, 2021
Advances in treatment of elderly primary central nervous system lymphomaNicolas Martinez-Calle, Lisa K Isbell, Kate Cwynarski, et al.
BMC Cancer|March 31, 2019
Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patientsElisabeth Schorb, Juergen Finke, Gabriele Ihorst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 25, 2010
Primary CNS lymphoma--radiation-free salvage therapy by second autologous stem cell transplantationBenjamin Kasenda, Elisabeth Schorb, Kristina Fritsch, et al.
International Journal of Adolescent Medicine and Health|December 23, 2008
Marked smoking-associated increase of cardiovascular risk in childhood type 1 diabetesKarl Otfried Schwab, Jürgen Doerfer, Kristiane Hallermann, et al.
Blood Advances|July 30, 2020
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot studyElisabeth Schorb, Benjamin Kasenda, Gabriele Ihorst, et al.
Cancers|September 10, 2021
Treatment Regimens for Immunocompetent Elderly Patients with Primary Central Nervous System Lymphoma: A Scoping ReviewElisabeth Schorb, Lisa Kristina Isbell, Gerald Illerhaus, et al.
Annals of Hematology|March 30, 2012
The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patientsBenjamin Kasenda, Marcel Rehberg, Petra Thürmann, et al.
Pageof 5